Pre-IND Prep: A Primer
Source: Thermo Fisher Scientific
Meet Daniela Drago, Ph.D. and Helen Kim, regulatory affairs experts at NDA Partners and Umoja Biopharma, respectively, and tune in for the opening segment of our recent live panel discussion on risk-proofing your IND submission. In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, Drago and Kim address two of the most common IND mistakes biopharmas make—neglecting the value of a pre-IND meeting, and underestimating the time and energy required of successful submissions.
View the full presentation on-demand here.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more